Medical technology firm ConMed has completed its acquisition of endoscopic technologies from Murray Hill, NJ-based interventional technology provider C.R. Bard.
The division acquired by ConMed of Billerica, MA, offers a comprehensive line of single-use medical devices employed to diagnose and treat diseases of the digestive tract and lungs using minimally invasive endoscopic techniques. The acquired endoscopic product line had 2003 revenues approximating $54 million, and is the third-largest domestic supplier of these types of products to the market, according to Utica, NY-based ConMed.
By AuntMinnie.com staff writers
October 1, 2004
Related Reading
Settlement in Immunomedics patent case, September 30, 2004
Bard to unload endoscopic assets, August 18, 2004
Bard ups Q1 forecast, March 10, 2004
Bard gets added clearance for vena cava filter, August 12, 2003
Ring takes over at Bard, August 8, 2003
Copyright © 2004 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)